Abstract # 2125 Concurrent Chemoradiotherapy with Full-dose Gemcitabine for Unresectable Pancreatic Cancer

Presenter: Nakamura, Satoaki

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos


Results:
All patients planned to deliver the dose of 30 and 40 Gy completed our therapy. Of the 85 patients planned to deliver the dose of 50 Gy, 79 completed all protocol therapy. PTV are varied from 65 cm3 to 682 cm3 (median 157 m3). Median overall survival (OS) was 15.7 months. The 1- and 2-year OS were 61% and 26%, respectively. Six patients (6%) had significant gastrointestinal (GI) bleeding (Grade 3+).